Origimm is a biotech startup company located in Vienna, Austria. We are discovering highly efficacious vaccine candidate antigens, based on our proprietary antigen discovery technology, ProVaDis (Protection-based Vaccine Discovery). We are also developing a novel treatment against acne, based on a prototype vaccine against acne associated bacteria.
